American Association for the Advancement of Science, Science Translational Medicine, 601(13), 2021
DOI: 10.1126/scitranslmed.abe8573
Full text: Unavailable
An engineered commensal bacteria with a surface-expressed vaccine target provoked antigen-specific antibodies during pharyngeal carriage in humans.